COMPANY SANITIZED PUBLIC COPY OCTOBER 30, 2009 

# Appendix D Facility Report on Product Content Fluoroelastomers COMPANY SANITIZED PUBLIC COPYCOMPANY SANITIZED PUBLIC COPY OCTOBER 30, 2009 

## 2010/15 PFOA Stewardship Program 

# Facility Report on Product Content

COMPANY SANITIZED PUBLIC COPY I. CHEMICAL IDENTIFICATION Identify the pro duct (e.g ., fluoropolymer dispersion) for which you are submitting information: Product name: Fluoroelastomer

Product description (including concentrations of perfluoroalkyl chemicals identified in Section IV below and year of production): Elastomer made from fluorinated monomers in aqueous dispersion with the ammonium salt of PFOA, i.e. Octanoic acid, pentadecafluoroammonium salt (CAS 3825 - 26- 1) II. COMPANY IDENTIFICATION Identify the company and location of the facility submitti ng information:

Company name : DuPont Performance Elastomers LLC Site location: [ CBI ] Identify a company technical contact who can respond to inquiries about the information submitted: Technical contact: Pascal Ferrandez

Phone: 240 994 4967 Address: Bellevue Parkway Corporate Center, Suite 300

300 Bellevue Parkway Wilmington DE 19809COMPANY SANITIZED PU BLIC COPY OCTOBER 30, 2009 III. PRODUCTION Calendar year for which you are reporting : Jan 1, 200 8 _ to Dec 31, 200 8 Provide the amount of the product for the reporting year at each specific site:

Imported (not reported) kgs/yr Manufactured [ CBI ] IV. PRODUCT CONTENT A. CONCENTRATIONS OF RELEVANT PE RFLUOROALKYL CHEMICALS Please provide the concentrations (ppb) of various perfluoroalkyl chemicals in your product. For chemicals for which you do not have actual data, please provide range estimates. The following is a nonexhaustive list of chemicals t hat should be included: PFOA and its salts  Octanoic acid, pentadecafluoro- (CAS 335 - 67- 1)  Octanoic acid, pentadecafluoro- ammonium salt (CAS 3825 - 26- 1) PFOA precursors  Octane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7, 8,8- heptadecafluoro - 8 - iodo - (CAS 507 - 63- 1)  1 - De canol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10 - heptadecafluoro - (CAS 678 -39 - 7)  1 - Decene, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10 - heptadecafluoro - (CAS 21652 - 58 - 4)  2 - Propenoic acid, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10 - heptadecafluorodecyl ester (CAS 27905 - 45 - 9)  2 - Propenoic acid, 2 -

methyl - , 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10- heptadecafluorodecyl ester (CAS 1996 - 88- 9)  2 - Decenoic acid, 3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10 - hexadecafluoro - (CAS 70887 - 84- 2)  Decanoic acid, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10 - heptadec afluoro- (CAS 27854 - 31 - 5) Higher homologues  Dodecane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12- pentacosafluoro- 12 -

iodo - (CAS 307 - 60 -8)  Decane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10- heneicosafluoro - 10 - iodo - (CAS 423- 62 - 1)  Nonanoic acid, heptadecafluoro - (CAS 375 - 95 - 1)COMPANY SANITIZED PU BLIC COPY OCTOBER 30, 2009 Part IV (cont.)

 Decanoic acid, nonadecafluoro - (CAS 335 - 76 - 2)  1 - Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10 - heptadecafluoro - (CAS 678 -39 - 7)  Decane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8- heptadecafluoro - 10 - iodo - (CAS 2043 - 53 - 0)  Dodecane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10- heneicosafluoro- 12 - iodo - (CAS 2043- 54 - 1)  2 - Propenoic acid, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10 - heptadecafluorodecyl ester (CAS 4980

- 53 - 4)  2 - Propenoic acid, 2 -

methyl - , 3,3,4,4,5,5,6,6,7,7,8,8, 9,9,10,10,11,11,12,12,12 - heneicosafluorododecyl ester (CAS 17741 -60 - 5) B. ANALYTICAL METHODS The method of analysis consisted of a process of extraction using high purity methanol as the solvent, followed by LC- MS - MS analysis of the extract as described in the following article: Larsen, B. S.,Kaiser, M. A., Botelho, M., Wooler, G. R., Buxton, L. W. Comparison of Pressurized Solvent and Reflux Extraction methods for the determination of perfluorooctanoic acid in polytetrafluoroethylene polymers using LC - MS - MS. Analyst . 2005, 130 , 59 -62.COMPANY SANITIZED PUBLIC COPY OCTOBER 30, 2009

SECTION 4 : SUMMARY OF PRODUCT CONTENT Fluoroe lastomers Company Sanitized Public Copy Reporting Period (use calendar year - e.g. Jan 1, 2005 to Dec 31, 2005) January 1, 2008

– December 31, 200 8 Product type Fluoropolymer dispersions Other fluoropolymers i Telomer based p roducts 4a Production v olume (kgs/year) ii Concentrationiii % Reduction from baseline year Operations Chemical category Fluoropolymer dispersions

iv (ppm wetweight ) Other

fluoropolymers 1, v (ppb dry weight ) Telomer based

p roducts vi (ppb dry weight ) Fluoropolymer

dispersions Other

fluoropolymers 1 Telomer

based p roducts PFOA, PFOA salts and higher homologues Fluoroelastomers 1 3 ,000 ppb (1 3 ppm) 96% 4b U . S . facilities Precursors

PFOA, PFOA salts and higher homologues Fluoroelastomers 0 ppb 100% 4 c Non- U . S . facilities Precursors Please provide information on the methods, assumptions, uncertainties and detection limits for the data provided above.

4 d Fluoroela stomers content: analytical measurement GC/ECD (Gas Chromatography / Electron Capture Detection) with LOD 1 ppm on limited but representative sample of past production, as elimination of use of PFOA occurred in 2001 for the manufacturing of most fluoroelas tomers. Current production analyzed with LC/MS/MS (Liquid Chromatography Mass Spectrometry Triple Quad) with LOD of 30 ppt after Pressurized Solvent Extraction Technique , as described in the following article: Larsen, B. S.,Kaiser, M. A., Botelho, M., Woo ler, G. R., Buxton, L. W. Comparison of Pressurized Solvent and Reflux Extraction methods for the determination of perfluorooctanoic acid in polytetrafluoroethylene polymers using LC - MS - MS. Analyst . 2005, 130 , 59- 62.COMPANY SANITIZED PUBLIC COPY OCTOBER 30, 2009 i Fluoropolymers manufactured with PFOA. ii Use the following ranges: (1) Zero (2) > 0

– 10 kgs; (3) > 10 kgs

– 100 kgs ; ( 4 ) > 10 0 kgs

– 1,000 kgs; (5) > 1,000 kgs

– 10 ,000 kgs ; (6) > 10,000 kgs

– 100,000 kgs ; (7) > 100,000 kgs

– 1,000,000 kgs; (8) Over 1,000,000 kgs. iii Concentration should reflect the concentration of chemical in the product as sold by the reporting company. If the reporting company has information c oncerning the concentration of chemical in the product as used by others

– for example, as incorporated by dilution into a formulation

– that additional information would also be helpful. iv This value should be expressed as a weighted average concentration and range. v This value should be expressed as a maximum concentration. vi This value should be expressed as a simple (not weighted) average and range.